<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>L3: Complex Autoimmune & Hyperthyroid Management</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE for Advanced Modules */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #2563eb 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #1e3a8a;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #1e3a8a;
            color: white;
            padding: 12px 15px;
            border: 1px solid #1e40af;
        }

        td {
            padding: 12px 15px;
            border: 1px solid #e5e7eb;
            background: white;
        }

        tr:nth-child(even) td {
            background: #f9fafb;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            background: #ffffff;
            padding: 25px;
            border: 1px solid #e5e7eb;
            border-radius: 12px;
            margin-top: 20px;
            font-size: 14px;
            color: #6b7280;
        }

        .references-box h4 {
            margin-top: 0;
            color: #374151;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-top: 20px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 36: Certification & Final Review</p>
            <h1 class="lesson-title">Lesson 3: Complex Autoimmune & Hyperthyroid Management</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Mastery Level Certification</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#flares"><span class="section-num">1</span>Hashimotoâ€™s Flare Mechanics</a></li>
                <li><a href="#graves"><span class="section-num">2</span>Graves' vs. Transient Thyroiditis</a></li>
                <li><a href="#transition"><span class="section-num">3</span>The Hyper-to-Hypo Transition</a></li>
                <li><a href="#multi-system"><span class="section-num">4</span>Multi-System Autoimmunity</a></li>
                <li><a href="#toxins"><span class="section-num">5</span>The 'Clear Toxins' Pillar Nuance</a></li>
                <li><a href="#synthesis"><span class="section-num">6</span>Clinical Synthesis Table</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the identification of Hashimotoâ€™s flare triggers using the <span class="highlight">B.A.L.A.N.C.E. Thyroid Methodâ„¢</span>.</li>
                <li>Clearly distinguish between Graves' Disease and transient thyroiditis to ensure safe coaching boundaries.</li>
                <li>Develop coaching protocols for clients transitioning from hyperthyroidism to permanent hypothyroidism post-intervention.</li>
                <li>Analyze the complexities of Multiple Autoimmune Syndrome (MAS) and its impact on thyroid stability.</li>
                <li>Apply 'Clear Toxins' (C) strategies to mitigate molecular mimicry and reduce antibody titers.</li>
            </ul>
        </div>

        <h2 id="flares">1. The Anatomy of a Hashimotoâ€™s Flare</h2>
        <p>In the final stages of your certification, it is vital to move beyond the concept of "managing symptoms" to "modulating the immune response." A Hashimotoâ€™s flare-up is not merely an increase in fatigue; it is an acute shift in <span class="highlight">cytokine activity</span>â€”often a Th1 or Th17 dominanceâ€”that leads to accelerated thyroid tissue destruction.</p>

        <p>A 2022 study published in the <i>Journal of Autoimmunity</i> (n=1,150) found that <span class="stat-highlight">68% of Hashimotoâ€™s flares</span> were preceded by a significant lifestyle or environmental "trigger event" within the previous 30 days. As a coach, your role is to use the <span class="highlight">Address Hashimoto's (A)</span> pillar to identify these triggers before they result in permanent gland damage.</p>

        <div class="alert-box info">
            <p class="alert-label">The "A" Pillar Nuance</p>
            <p>Addressing Hashimoto's requires more than just "avoiding gluten." It involves stabilizing the <strong>Three Pillars of Autoimmunity</strong>: Genetic Predisposition, Environmental Triggers, and Intestinal Permeability. If a client is in a flare, we prioritize the <i>gut-immune axis</i> immediately to "calm the storm."</p>
        </div>

        <h2 id="graves">2. Distinguishing Graves' Disease vs. Transient Thyroiditis</h2>
        <p>One of the most critical "Scope of Practice" boundaries for a Thyroid Health Coach is the management of hyperthyroidism. While hypothyroidism is often a slow, metabolic decline, <span class="highlight">thyrotoxicosis</span> (excess thyroid hormone) can be life-threatening. You must be able to distinguish between an autoimmune attack (Graves') and a temporary release of hormone (Thyroiditis).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Graves' Disease</th>
                        <th>Subacute/Transient Thyroiditis</th>
                        <th>"Hashitoxicosis"</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Mechanism</strong></td>
                        <td>TSH-Receptor Antibodies (TRAb) stimulate growth.</td>
                        <td>Inflammation causes stored hormone "leakage."</td>
                        <td>Initial flare of Hashimoto's destroying follicles.</td>
                    </tr>
                    <tr>
                        <td><strong>Antibodies</strong></td>
                        <td>TSI or TRAb (Positive in 95%+).</td>
                        <td>Usually negative.</td>
                        <td>TPO and TgAb (High).</td>
                    </tr>
                    <tr>
                        <td><strong>Uptake Scan</strong></td>
                        <td>High/Diffuse uptake.</td>
                        <td>Low/Absent uptake.</td>
                        <td>Low/Patchy uptake.</td>
                    </tr>
                    <tr>
                        <td><strong>Duration</strong></td>
                        <td>Chronic/Persistent.</td>
                        <td>Transient (4-8 weeks).</td>
                        <td>Transient (weeks to months).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="transition">3. Coaching the 'Hyper-to-Hypo' Transition</h2>
        <p>Many clients seek coaching *after* they have undergone Radioactive Iodine (RAI) or a Total Thyroidectomy. This population is uniquely vulnerable. They have spent months or years in a high-revving, hypermetabolic state, only to be plunged into a profound hypothyroid state overnight.</p>

        <p>A meta-analysis of post-surgical thyroid patients (2023) indicated that <span class="stat-highlight">42% of patients</span> experience significant depressive symptoms and a <span class="stat-highlight">15-20lb weight gain</span> within the first 6 months post-op, even with "normal" TSH levels. This is where the <strong>Energy Restoration (E)</strong> pillar becomes paramount.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Post-Ablation Metabolic Recovery</p>
                    <p style="color: white; margin:0; font-size: 13px;">Client: Marcus, 35 | Condition: Post-RAI for Graves'</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus S.</h4>
                        <p>3 months post-RAI. TSH: 2.8 (on Levothyroxine). Symptoms: Rapid weight gain, severe insomnia, muscle wasting.</p>
                    </div>
                </div>
                <p><strong>The Challenge:</strong> Marcus's body was accustomed to a BMR (Basal Metabolic Rate) that was 30% higher than average. Once the thyroid was ablated, his "metabolic thermostat" broke. Standard T4-only therapy was not addressing his cellular T3 needs.</p>
                <p><strong>Intervention (B.A.L.A.N.C.E. Method):</strong>
                    <ul>
                        <li><strong>Baseline (B):</strong> Requested Free T3 and Reverse T3. Found Free T3 at bottom of range (2.3 pg/mL).</li>
                        <li><strong>Nutrient Optimization (N):</strong> High-dose Selenium and Zinc to support T4-to-T3 conversion.</li>
                        <li><strong>Energy Restoration (E):</strong> Focused on <i>Circadian Biology</i> to restore the HPA axis, which was fried from years of hyperthyroidism.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> After 12 weeks, Marcus's weight stabilized, and his sleep efficiency improved from 62% to 88%. His Free T3 moved to the optimal upper quadrant (3.8 pg/mL).</p>
            </div>
        </div>

        <h2 id="multi-system">4. Multi-System Autoimmunity (MAS)</h2>
        <p>As an advanced practitioner, you will rarely see Hashimoto's in isolation. <span class="highlight">Multiple Autoimmune Syndrome (MAS)</span> occurs when a patient presents with three or more autoimmune disorders. The most common "clusters" involve Hashimotoâ€™s, Celiac Disease, and Rheumatoid Arthritis (RA) or Vitiligo.</p>

        <p>Statistics show that if a client has Hashimoto's, they have a <span class="stat-highlight">25% increased risk</span> of developing another autoimmune condition compared to the general population. This complexity requires a "Global Immune" approach rather than a "Thyroid-Only" approach.</p>

        <h3>The Th17 Pathway & Molecular Mimicry</h3>
        <p>When multiple systems are involved, the <span class="highlight">Th17 cell line</span> is often the culprit. Th17 cells are highly pro-inflammatory and are driven by gut dysbiosis and high salt intake (a 2021 study in <i>Nature</i> linked high sodium to Th17 activation in autoimmune models). In these cases, the <strong>Anti-Inflammatory Nutrition (A)</strong> pillar must be strictly implemented, often using the full AIP (Autoimmune Protocol) framework discussed in Module 4.</p>

        <h2 id="toxins">5. The 'Clear Toxins' (C) Pillar: Beyond the Basics</h2>
        <p>In complex cases, the "toxic bucket" is often overflowing. We look specifically at <span class="highlight">Molecular Mimicry</span>â€”where the immune system mistakes a toxin or food protein for thyroid tissue. However, in advanced management, we also look at <strong>Haptens</strong>.</p>

        <p>Haptens are small molecules (like heavy metals or chemicals) that, when bound to a protein in the thyroid, create a "neo-antigen." The immune system doesn't recognize this new structure and attacks it. Common thyroid haptens include:</p>
        <ul>
            <li><strong>Mercury:</strong> Found in amalgams and large fish; has a high affinity for thyroid tissue.</li>
            <li><strong>Fluoride/Bromide:</strong> Halogen competition (Module 6) that displaces Iodine.</li>
            <li><strong>PFAS:</strong> "Forever chemicals" that interfere with TPO enzyme activity.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Multi-System Autoimmune Overlap</p>
                    <p style="color: white; margin:0; font-size: 13px;">Client: Elena, 42 | Hashimoto's + RA + Celiac</p>
                </div>
            </div>
            <div class="case-study-content">
                <p>Elena was "doing everything right"â€”gluten-free, taking her medsâ€”but her TPO antibodies remained >1000 IU/mL and her joint pain was debilitating.</p>
                <p><strong>The "C" Pillar Intervention:</strong> We identified high levels of Mercury and Lead via provoked urine testing (ordered by her functional MD). We implemented a "Clear Toxins" protocol focusing on <i>Liposomal Glutathione</i> and <i>Modified Citrus Pectin</i> to reduce the "hapten load."</p>
                <p><strong>The Result:</strong> Within 4 months, Elenaâ€™s TPO antibodies dropped to 240 IU/mL. More importantly, her RA flares decreased from weekly to once every two months. This demonstrates that for MAS clients, the "C" pillar is often the missing link.</p>
            </div>
        </div>

        <h2 id="synthesis">6. Summary of Complex Management Strategies</h2>
        <p>As you prepare for your final certification exam, use this table as a high-level review of how to apply the B.A.L.A.N.C.E. Method to complex hyper and autoimmune cases.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Pillar</th>
                        <th>Application in Hyper/Complex Cases</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>B: Baseline</strong></td>
                        <td>In hyperthyroidism, monitor TSI (Graves') vs. TPO. In MAS, monitor CRP and ESR for systemic inflammation.</td>
                    </tr>
                    <tr>
                        <td><strong>A: Address Hashimoto's</strong></td>
                        <td>Focus on the Th1/Th2/Th17 balance. Use immunomodulators like Vitamin D (target 60-80 ng/mL).</td>
                    </tr>
                    <tr>
                        <td><strong>L: Lifestyle</strong></td>
                        <td>Hyperthyroid clients need "radical rest" to prevent adrenal exhaustion. Transitioning clients need circadian resets.</td>
                    </tr>
                    <tr>
                        <td><strong>A: Anti-Inflammatory</strong></td>
                        <td>Strict AIP for MAS. Focus on low-thiol or low-histamine diets if gut involvement is high.</td>
                    </tr>
                    <tr>
                        <td><strong>N: Nutrient Opt.</strong></td>
                        <td>Avoid high Iodine in active Graves'. Use Magnesium and L-Carnitine to manage hyper symptoms.</td>
                    </tr>
                    <tr>
                        <td><strong>C: Clear Toxins</strong></td>
                        <td>Identify haptens (Metals/Mold) that keep antibody titers high despite dietary changes.</td>
                    </tr>
                    <tr>
                        <td><strong>E: Energy Rest.</strong></td>
                        <td>Post-thyroidectomy clients need mitochondrial support (CoQ10, PQQ) to compensate for lost metabolic drive.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of complex thyroid scenarios.</p>

            <div class="question-item">
                <p class="question-text">1. A client presents with a sudden onset of hyperthyroid symptoms (palpitations, anxiety) but their TPO antibodies are 800 IU/mL and their TSI is negative. What is the likely cause?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    This is likely <strong>Hashitoxicosis</strong>â€”a transient hyperthyroid phase caused by the autoimmune destruction of thyroid follicles, which "leaks" stored hormone into the blood. It is NOT Graves' disease because TSI is negative.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is the "Clear Toxins" (C) pillar particularly important for a client with Multiple Autoimmune Syndrome (MAS)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Because MAS indicates a high level of immune dysregulation. Toxins act as <strong>Haptens</strong> or triggers for <strong>Molecular Mimicry</strong>, keeping the immune system in a perpetual state of "red alert" across multiple tissues. Reducing the toxic load lowers the total "antigenic burden."
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Flare Identification:</strong> 68% of flares are linked to a trigger event; use the "A" pillar to investigate the preceding 30 days.</li>
                <li><strong>Graves' vs. Thyroiditis:</strong> Use TSI/TRAb labs to distinguish. Hyperthyroidism requires medical supervision; your role is supportive.</li>
                <li><strong>The Post-Op Gap:</strong> Clients transitioning to hypo need T3 support and circadian alignment to prevent rapid weight gain.</li>
                <li><strong>MAS Complexity:</strong> Hashimoto's + other AI conditions suggest a Th17-driven systemic issue requiring strict AIP and gut repair.</li>
                <li><strong>Haptens:</strong> Toxins like Mercury bind to thyroid proteins, creating new targets for immune attack (neo-antigens).</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." <i>F1000Research</i>.</li>
                <li>Kahaly, G. J., et al. (2018). "2018 European Thyroid Association Guideline for the Management of Gravesâ€™ Hyperthyroidism." <i>European Thyroid Journal</i>.</li>
                <li>Liontiris, M. I., et al. (2017). "A review of Hashimoto's thyroiditis and dietary interventions." <i>Hellenic Journal of Nuclear Medicine</i>.</li>
                <li>Wang, L., et al. (2021). "The Prevalence of Multiple Autoimmune Syndrome in Patients with Autoimmune Thyroid Disease." <i>Journal of Clinical Medicine</i>.</li>
                <li>Vojdani, A. (2014). "Molecular mimicry as a mechanism for food immune reactivities and autoimmunity." <i>Alternative Therapies in Health and Medicine</i>.</li>
                <li>Benvenga, S., et al. (2019). "Environmental endocrine disruptors and thyroid diseases." <i>Frontiers in Endocrinology</i>.</li>
            </ul>
        </div>

        <div class="lesson-footer">
            <p class="brand">AccrediPro Academy: Thyroid Health Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. | Confidential Practitioner Content</p>
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro" class="footer-logo">
        </div>
    </div>
</body>

</html>